Efficacy and Safety of Empagliflozin in the Management of Diabetes Mellitus in Heart Transplant Recipients

BACKGROUND. Type 2 diabetes mellitus (T2DM) is prevalent in patients undergoing heart transplant, and in those without preexisting T2DM, posttransplant diabetes mellitus may develop. Both T2DM and posttransplant diabetes mellitus have been associated with increased morbidity and mortality following...

Descripción completa

Detalles Bibliográficos
Autores principales: Cehic, Matthew G., Muir, Christopher A., Greenfield, Jerry R., Hayward, Christopher, Jabbour, Andrew, Keogh, Anne, Kotlyar, Eugene, Muthiah, Kavitha, Macdonald, Peter S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Heart Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511439/
https://www.ncbi.nlm.nih.gov/pubmed/31165085
http://dx.doi.org/10.1097/TXD.0000000000000885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511439/
https://www.ncbi.nlm.nih.gov/pubmed/31165085
http://dx.doi.org/10.1097/TXD.0000000000000885

Ejemplares similares